Breaking News

Aesica, Britest in Manufacturing Solutions Pact

February 14, 2013

Aims to identify and commercialize new technologies

Aesica has entered into a collaboration with Britest under whichmembers will share knowledge and risk to establish innovative solutions to manufacturing challenges. Britest has engaged 22 global chemical and pharmaceutical organizations and several academic organizations. The partnerships will utilize and further develop Britest’s tools and methodologies to support whole process understanding. Aesica will use these tools to identify new approaches and technologies to improve API manufacturing processes. The Aesica Innovation Board (AIB) aims to commercialize any new technologies.
Dr. Barrie Rhodes, Aesica director of technology development, said, “At Aesica we aspire to develop and implement new technologies and improve processes to support business growth. Following the successful demonstration of the Britest approach on a key Active Pharmaceutical Ingredient process at our Cramlington site, we are now looking forward to engaging fully in the Britest collaboration and implementing the Britest approach across a range of processes.”
Sue Fleet, Britest chief executive officer, said, “I am delighted to welcome Aesica Pharmaceuticals as our latest company member. With a clear focus on innovation and collaboration, we look forward to supporting Barrie and his colleagues at Aesica in driving innovative thinking and deriving full value from their membership of Britest.”

blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016